Poxviruses rely on host factors for most stages of their life cycle, including attachment to 46 the cell and entry. These host factors are crucial for virus infectivity and host cell tropism. 47
Abstract

24
Vaccinia virus is a promising viral vaccine and gene delivery candidate, and has historically 25 been used as a model to study poxvirus-host cell interactions. We employed a genome-wide 26 insertional mutagenesis approach in human haploid cells to identify host factors crucial for 27 vaccinia virus infection. A library of mutagenized HAP1 cells was exposed to Modified 28 Vaccinia Virus Ankara (MVA). Deep-sequencing analysis of virus-resistant cells identified 29 host factors involved in heparan sulfate synthesis, Golgi organization, and vesicular protein 30 trafficking. We validated EXT1, TM9SF2 and TMED10 (TMP21/p23/p24δ) as important host 31 factors for vaccinia virus infection. The critical role of EXT1 in heparan sulfate synthesis and 32 vaccinia virus infection was confirmed. TM9SF2 was validated as a player mediating heparan 33 sulfate expression, explaining its contribution to vaccinia virus infection. In addition, 34 TMED10 was found to be crucial for virus-induced plasma membrane blebbing and 35 phosphatidylserine-induced macropinocytosis, suggesting that TMED10 regulates actin 36 cytoskeleton remodelling necessary for virus infection. 37 38 Importance 39 Poxviruses are large DNA viruses that can infect a wide range of host species. A number of 40 these viruses are clinically important to humans, including variola virus (smallpox) and 41 vaccinia virus. Since the eradication of smallpox, zoonotic infections with monkeypox virus 42 and cowpox virus are emerging. Additionally, poxviruses can be engineered to specifically 43 target cancer cells, and are used as vaccine vector against tuberculosis, influenza, and 44 coronaviruses. 45 Introduction 57 58
The poxvirus family represents a group of large enveloped DNA viruses that infect a wide 59 variety of hosts. Poxvirus species capable of infecting humans include variola virus, which 60 causes smallpox and is one of the most destructive pathogens in human history. Since its 61 eradication through successful vaccination using vaccinia virus, poxvirus outbreaks in 62 humans are nowadays mainly caused by zoonotic infections of cowpox virus, monkeypox 63 virus, and recently discovered poxvirus species (1-3). The number of zoonotic infections is 64 predicted to rise, due to waning population immunity (4). In part, the decreased immunity is 65 caused by concerns about vaccinia virus safety, as a minority of vaccinated individuals show 66 adverse side effects (5). These safety concerns have led to the development of safer, 67 attenuated vaccinia virus strains, including the Modified Vaccinia Ankara virus (MVA). By 68 passaging vaccinia virus over 500 times on chicken embryo fibroblasts, the resulting 69 attenuated MVA lost 10% of the parental vaccinia genome, and displays an abortive 70 replication cycle in most cell lines (6) . MVA is potent vaccine against poxviruses and serves 71 as a vaccine vector against a variety of other diseases (7) (8) (9) (10) (11) (12) (13) . 72 Due to their low pathogenicity and wide range of applications, vaccinia virus strains are used 73 as model viruses to study the unique life cycle of poxviruses (14) . The vaccinia virus life cycle 74 starts with binding to heparan sulfate (HepS) and other glycosaminoglycans expressed on 75 the host cell, although laminin and unidentified cellular proteins may also play a role (15) . 76
Upon binding, the viral envelope fuses with the host cell at either the plasma membrane or 77 the endosomal membrane after macropinocytotic uptake by the host (16). Release of the 78 virus core in the cytoplasm initiates transcription of more than 100 viral genes (17) 
Insertional mutagenesis 110
Mutagenesis of HAP1 cells using a retroviral gene trap vector was performed as described 111 previously (20) . For the screen, 1x10 8 cells were infected with MVA-eGFP (MOI 50), and 112 surviving cells were expanded and harvested for genomic DNA isolation. Retroviral insertion 113 sites were amplified using a linear amplification-mediated PCR and deep-sequenced 114 (Illumna HiSeq 2000) . Sequences were aligned to the human genome (hg19) to identify 115 retroviral insertion sites, which were assigned to non-overlapping protein-coding Refseq 116 genes. Because the gene trap cassette was designed unidirectionally, genes functioning as 117 MVA host factors would be predicted to be enriched for disruptive orientation insertions 118
(21), as tested by a binomial test and corrected for multiple testing (Benjamini and 119 Hochberg FDR). Genes already enriched in an unselected wildtype HAP1 dataset (NCBI 120 Sequence Read Archive accession no. SRX1045466) were discarded. 121 122
Lentiviral vectors 123
The selectable lentiviral CRISPR/Cas vector used in this study was previously described (22) . 124
This vector contains a human codon-optimized S. pyogenes Cas9 gene including a nuclear 125 localization signal (NLS) at the N-and C-terminus. At the N-terminus, Cas9 is fused to PuroR 126 via a T2A ribosome-skipping sequence under control of the human EF1A promoter. 127
Additionally, it contains a human U6 promoter which drives expression of a guideRNA 128 (gRNA) consisting of an 18-20bp target-specific CRISPR RNA (crRNA) fused to the trans-129 activating crRNA (tracrRNA) and a terminator sequence. This vector is called pSicoR-CRISPR-130 PuroR and has been described previously (22) . 131
The crRNA target sequences for each of the targeted genes were designed using an online 132 CRISPR design tool (crispr.mit.edu; Zhang lab, MIT). CRISPR gRNAs with the highest 133 specificity and lowest off-target rate for the human genome were selected and cloned into 134 the pSicoR-CRISPR-PuroR vector using Gibson assembly (NEB TM9SF2#1  TM9SF2  GTTCCTGGCCCGCGCCGGAG   TM9SF2#2  TM9SF2  GCAGGTAGAAAGCGCCGCTC   TM9SF2#3  TM9SF2  GAAGTTGACGGGCGCCAGGC   TM9SF2#4  TM9SF2  GGTCAGAGGTTCTGTAATCC   TM9SF2#5  TM9SF2  GCAGTCTGGTTTATCTATAT   TMED10#1  TMED10  GGCCGCCAGCGCCCCCAGAC   TMED10#2  TMED10  GTCGCCTTCCCCCTCACCGT   TMED10#3  TMED10  GCCACCTCAAGGTGCGGCAT   TMED10#4  TMED10  GAGGCACTTGCGAGAGTTAA  TMED10#5  TMED10 
Lentivirus production and transduction 144
Third generation lentiviruses were produced in HEK-293T cells in a 24 well plate format 145 using standard lentivirus production protocols. MJS cells were transduced using spin 146 infection at 1,000 x g for 90 minutes at 33°C in the presence of 3.2 µg/ml polybrene. After 3 147 days, transduced cells were selected using zeocin (400 µg/ml). 148 149 Generation of knockout cell lines 150 MJS cells or HeLa cells were transfected with pSicoR_CRISPR_PuroR encoding the indicated 151 gRNA (table 1), and subsequently selected using puromycin for 2 days (2 µg/ml). Clonal lines 152 were generated by limited dilution after selection. 153 154
Virus infections 155
For the validation in polyclonal MJS cell lines, 2 x 10 4 cells/well were seeded in a 48 wells 156 plate and infected the following day with MVA-eGFP using an MOI of 50. After seven days of 157 infection, cells were harvested and the amount of cells was quantified by flow cytometry. 158
Prior to flow cytometric analysis, 3,300 mCherry-positive T2 cells were mixed in to allow for 159 normalization for cell counts between samples. 160
For infections in clonal Hela and MJS cells, 2,5 x 10 4 cells were seeded in a 48 wells plate and 161 infected the following day with the indicated virus strain at the MOI indicated. were mixed in a glass tube, and chloroform was subsequently evaporated with dry nitrogen 218 gas. The yielded lipid film was subsequently kept in a vacuum desiccator for 20 min. Lipid 219 films were hydrated for 30 min in buffer containing 10 mM Tris, 50mM NaCl (pH 7.4) 220 resulting in total lipid concentration of 10 mM. For calcein-encapsulated LUVs, 50 mM of 221 calcein was added during hydration. The lipid suspensions were freeze-thawed for 10 cycles, 222 at temperatures of -80 and +40°C, and eventually extruded 10 times through 0.2 μM-pore 223 size filters (Anotop 10, Whatman, UK). Free calcein was separated from calcein-filled LUVs 224 using size exclusion column chromatography (Sephadex G-50 fine) and eluted with 10 mM 225 Tris-HCl, 150mM NaCl buffer (pH 7.4). The phospholipid content of lipid stock solutions and 226 vesicle preparations were determined as inorganic phosphate according to Rouser (23) . To identify host factors involved in MVA infection, we performed a genome-wide haploid 245 genetic screen using HAP1 cells, which are readily infected and ultimately killed by MVA. A 246 total of 1 x 10 8 HAP1 cells were mutagenized using a gene trap retrovirus and subsequently 247 infected with MVA. Resistant HAP1 cells were propagated for ten days and their retroviral 248 insertion sites were subsequently identified by deep sequencing to recognize the disrupted 249 genes. Genes that were enriched for disruptive gene trap mutations in the virus selected 250 population but not in uninfected control cells were identified ( fig. 1 and table S1 ). Stongest 251 outliers were host factors that directly affect HepS chain formation, including XYLT2, 252 B4GALT7, B3GALT6, B3GAT3, EXTL3, EXT1, EXT2, HS2ST1 ,and NDST1 (reviewed by (24)). 253
Other host factors affecting HepS transport and biosynthesis of HepS precursor molecules 254 were also enriched in the screen, including UGDH, UXS1 SLC35B2, and PTAR1 (20, 21, 25-255 28) . A second cluster of host factors identified in the screen included all the subunits of the 256 Conserved Oligomeric Golgi (COG) complex. This complex is involved in the distribution of 257 glycosylation enzymes in the Golgi (29), and thereby indirectly affects HepS expression (20) . 258
Several other significant hits did not cluster with other genes for functional relationship, and 259 were involved in multiple cellular processes, including protein and vesicle trafficking, 260 ubiquitination, and Golgi organization. 261 262
Validation of hits using the CRISPR/Cas9 system 263
We used the CRISPR/Cas9 system to validate the a number of hits, including EXT1, TM9SF2, 264 TMED10, and SACM1L. These genes were selected based on the significance of the 265 enrichment and biological interest. In addition, mindbomb protein 1 (MIB1) was selected as 266 a hit that was already significantly enriched in wild type HAP1 cells (see table S1). Up to five 267 gRNAs per gene were selected and co-expressed with Cas9 in the human melanoma cell line 268 MelJuSo (MJS), which was readily infected by the poxviruses used in this study. In addition, 269 control gRNAs were expressed that target TAP1, TAP2, or B2M, which have no known role in and was more recently identified as a crucial factor for N-deacetylase/N-sulfotransferase 1 292 (NDST1) localization and functioning(30). We tested the effect of the EXT1 and TM9SF2 293 gRNAs on HepS surface expression in the same clones presented in fig. 3a . In the EXT1 294 gRNA-expressing clones that were resistant to primary MVA infection, HepS surface 295 expression was reduced to background levels. In contrast, EXT1 clone 2, which was not 296 resistant to MVA infection, displayed unaltered HepS surface levels ( fig. 3B ). Similar results 297 were obtained for the TM9SF2 clones, although the downregulation of HepS surface levels 298 was less pronounced as compared to the EXT1 clones. A total of 11 TM9SF2 clones were 299 tested for their resistance to MVA infection and HepS surface expression. These clones 300 displayed varying levels of HepS surface expression, which correlated with MVA infection 301 ( fig. 3C) . These results confirm a key role for EXT1 and TM9SF2 in HepS surface expression. 302 303 TMED10 is necessary for an early stage of vaccinia virus infection 304
Next, we tested the role of TMED10 in primary MVA infection of HeLa and MJS cells. 305 TMED10 gRNA-expressing HeLa and MJS cells were cloned and tested for TMED10 306 expression by immunoblotting ( fig. 4A ). Although we could readily knock-out TMED10 from 307 MJS cells, we were not able to establish TMED10-null HeLa cells, suggesting that TMED10 is 308 essential in HeLa but not MJS cells ( fig. 4A ). In line with this, the TMED10 knockdown clones 309 we could establish in HeLa cells displayed decreased growth rate. In contrast, removing 310 TMED10 from MJS cells did not result in altered morphology or growth rate. 311
The role of TMED10 in primary infection was tested by infecting MJS TMED10 KO clones 312 with two recombinant MVA strains that express eGFP during infection controlled by either 313 an early/late or late promoter. To measure early promoter activity, eGFP expression was 314 evaluated 5h after infection ( fig. 4B ). In both TMED10 KO clones, infection was reduced 315 modestly but significantly compared to control cells. To test whether TMED10 knockout had 316 an enhanced effect during late stages of infection, cells were infected with MVA expressing 317 eGFP from a late promoter, and eGFP expression was monitored 24h after infection. Late 318 gene expression was affected to similar levels as early gene expression, suggesting that 319 TMED10 affects virus infection prior to early gene expression ( fig. 4B ). A similar reduction in 320 early and late gene expression was also observed in MJS EXT1 clone 1, thereby confirming 321 that EXT1 affects MVA infection before the onset of early gene expression ( fig. 4B ). 322
To test the role of TMED10 in infection with other vaccinia virus strains, MJS cells were 323 infected with vaccinia virus strain Western Reserve (VACV-WR) expressing eGFP from an 324 early/late promoter (VACV-eGFP). Five hours after inoculation, VACV-eGFP infection was 325 significantly more abrogated as compared to the infection with MVA, and showed a 326 reduction of over 50% when compared to control cells. VACV-WR infection was also highly 327 reduced in MJS EXT1 clone 1, although not as pronounced as for MVA. This is in line with 328 previous reports showing that VACV-WR is less dependent on HepS for attachment than the 329 MVA strain (31, 32)( fig. 4B ). Next, we tested the role of TMED10 in VACV-eGFP infection of 330 HeLa cells. Despite the incomplete removal of TMED10 protein from these cells ( fig. 4A) , 331 VACV-eGFP infection was reduced up to 50% in both HeLa TMED10 knockdown clones at 332 differtent MOIs. In the two MJS TMED10 KO clones, infection was again highly reduced at 333 both MOIs tested ( fig. 4C ). 334
To exclude that the observed phenotype was caused by off-targeting effects of the two 335 TMED10 gRNAs, the TMED10 cDNA was reintroduced in the MJS TMED10 KO clones by 336 means of lentiviral transduction ( fig. 4D ). Indeed, TMED10 reconstitution facilitated VACV-337 WR infection to similar levels as control cells ( fig. 4E ). Thus, we identified TMED10 as a new 338 host factor that affects vaccinia virus infection before the onset of early gene expression. 339
Similar to EXT1 and TM9SF2, TMED10 may affect HepS surface expression and thereby 340 impact attachment of the virus to the host cell membrane. However, both TMED10 KO MJS 341 clones displayed similar HepS surface levels as compared to wt MJS cells ( fig. 4F) . 342 Furthermore, TMED10 KO had no effect on VACV-WR binding to the host cell membrane, in 343 contrast to EXT1 and TM9SF2 KO cells ( fig. 4G ). To conclude, TMED10 affects poxvirus 344 infection post attachment but prior early gene expression, suggesting a role during virus 345 entry. in virus assembly (40). Therefore, host factors involved in later stages of infection are not 385 selected for in a given screen. Screening approaches using replication-competent vaccinia 386 viruses may elucidate more of these factors, although our initial results showed that such 387 viruses are too aggressive and did not allow recovery of virus-resistant cells. Another factor 388 that may contribute to the bias towards host factors affecting early stages of virus infection 389 is the selection method of this screen. This is based on resistance to virus-induced cell 390 death, and thereby does not account for selection of genes mediating virus production and 391 spread. In line with this, a haploid screen using replication-competent RVFV or pseudotyped 392 VSV also recovered host factors mostly involved in virus attachment and entry (20, 27, 41, 393 42) . 394
395
This study clearly illustrates the dominant role of HepS in vaccinia virus infection. This is in 396 line with previous studies showing that attachment of MVA and other vaccinia strains to the 397 host cell is primarily mediated by interactions with HepS on the cell surface (43) (44) (45) (46) . 398
Although MVA and VACV-WR infection is abrogated in the absence of HepS surface 399 expression, a proportion of the cells can still become infected (see fig. 3A and 4B) . It is 400 suggestive that attachment of viruses in the absence of HepS is mediated by other 401 glycosaminoglycans, including chondroitin sulfate and dermatan sulfate (47). Other factors 402 including the extracellular matrix protein laminin may also participate in virus 403 attachment(48). In addition, unidentified cell surface receptors have been implicated in 404 GAG-independent binding to the cell (15). Although our study did not reveal a specific MVA 405 attachment mediator, the preeminent role of HepS may mask the role for such alternative 406 entry mechanisms. In that respect, additional host factors could be identified by performing 407 a screen on HepS-deficient HAP1 cells. 408
The HepS-associated host factors identified in this screen largely overlap with factors 409 identified in haploid genetic screens performed for other viruses that (partly) depend on 410
HepS for host cell attachment, including Lassa virus, RVFV, and adeno-associated virus (27, 411 42, 49) . In addition, a haploid genetic screen that directly assessed the role of host factors 412 involved in HepS biosynthesis revealed a similar enrichment of genes and also identified 413 EXT1 as the most significant hit (42). Other genes that were enriched in these screens 414 included TM9SF2 and prenyltransferase alpha subunit repeat containing 1 (PTAR1). The 415 involvement of PTAR1 in HepS surface expression has been confirmed recently (20, 21, 27) . 416 TM9SF2 is a member of the highly conserved nonaspanin proteins that have been 417 connected to diverse cellular processes, most notably receptor trafficking, and cellular 418 adhesion (50, 51) . In addition, TM9SF2 affects the localization and stability of NDST1, which 419 is critical for N-sulfation of HepS (30). TM9SF2 single nucleotide polymorphisms have been 420 associated with several human diseases, including progression of AIDS(52). This association 421 may, in part, be explained by a TM9SF2-mediated decrease of HepS, thereby affecting 422 binding of HIV to the cell surface (53). 423
424
We identified TMED10 (also known as TMP21/p23/p24δ) as an important host factor for 425 VACV infection. TMED10 is a ubiquitously expressed type I transmembrane protein that 426 associates with coat complex protein I (COPI) vesicles through KKLIE motif in its cytosolic tail 427 (54, 55) . As such, it is suggested to function as a cargo receptor in retrograde vesicular 428 trafficking from the Golgi to the ER (54, 56, 57) . In addition, TMED10 localizes to the plasma 429 membrane independently of COPI (58). Plasma membrane-localized TMED10 controls the 430 activity of the presenilin/γ -secretase complex in neuronal tissue, thereby affecting the 431 formation of amyloid beta peptides implicated in Alzheimer's disease (59). Other binding 432 partners have also been described for TMED10, including ER-localized MHC class I (60), and 433 C1 domain-containing proteins such as the chimaerins (61, 62). These latter proteins are 434 critical regulators of the actin cytoskeleton modulator Rac1 (61-64). 435
The regulation of chimaerins by TMED10 may explain the effects on virus-induced 436 macropincotytosis observed in this study. Vaccinia-induced blebbing and subsequent 437 macropinocytosis critically depend on actin rearrangements regulated by the Rho GTPase 438 Rac1 (34, 35, 37, 65, 66) . Rac1 is deactivated by β2-chimaerin localized at the plasma 439 membrane (61). This localization is regulated by TMED10 that redistributes β2-chimaerin to 440 the perinucleus upon binding (61, 62) Conversely, depletion of TMED10 or disruption of the 441 β2-chimaerin/TMED10 complex relocates β2-chimaerin to the plasma membrane, and 442 thereby enhances Rac1 deactivation (61). Similarly, Rac1 deactivation in TMED10 KO cells 443 could explain the inhibitory effect on blebbing and macropinocytosis observed in this study. 444
We identified TMED10 as an important factor in PS-induced macropinocytosis. This pathway 445 is not only used by vaccinia viruses to enter cells; many other viruses expose PS to allow 446 entry by macropinocytosis (reviewed in (34)). In contrast to plasma membrane fusion, 447 macropinocytosis allows viruses to bypass the dense cortical actin layer to enter the cytosol. 448
Macropinocytosis also aids in immune escape of viruses, as this uptake pathway minimizes 449 exposure of viral antigens on the cell surface (16). In addition, viruses may benefit from the 450 dampening effect of PS-induced macropinocytosis on the immune system, which is 451 mediated by an array of anti-inflammatory cytokines (34, 67, 68 . 3A ) were infected with MVA-eGFP, MVA-eGFP late , or VACV-eGFP. After five hours, cells infected with MVA-eGFP, and VACV-eGFP were harvested to determine early promoter-driven eGFP expression of MVA-eGFP (MVA-early) or VACV-eGFP (VACV-early). After 20 hours of infection with MVA-eGFP late , cells were harvested to determine eGFP expression driven from a late promoter (MVA-late). S.E.M. of four independent experiments is shown. ns: not significant; *p<0.05; **p<0.0005. Significance was calculated using a two-tailed unpaired t-test. (C) MJS cells and HeLa cells indicated in (A) were infected with VACV-eGFP at either MOI of 10 or 20, and the percentage of infected (eGFP-positive) cells was quantified by flow cytometry. S.E.M. of three independent experiments is shown. (D) Wild type MJS cells or MJS clones indicated in (A) were transduced with an empty vector (+EV) lentivirus or a lentivirus encoding TMED10 (+TMED10). Transferrin receptor and TMED10 expression levels were assessed by immunoblotting. The immunoblot shown is representative of two independent experiments. (E) Wild type MJS cells or clones indicated in (D) were infected with VACV-eGFP. The percentage of infected (eGFP-positive) cells was quantified by flow cytometry five hours after infection. S.E.M. of four independent experiments is shown. (F) Flow cytometric analysis of wild type MJS (dashed line) and MJS TMED10 clones 1 and 2 (black lines) stained for HepS surface-expression, or secondary antibody only (gray filled line). (G) VACV-WR was allowed to bind control cells or indicated clones on ice. After one hour, cells were washed, fixed, and stained with an antibody specific for the viral H3 protein. Bound antibody was quantified by flow cytometry. The mean fluorescence intensity of the control cells was set at 100%. S.E.M. of three experiments is shown. 4D ) were incubated with VACV-WR (MOI 100) (+VACV) or left untreated (-VACV) for one hour on ice. Subsequently, the cells were incubated at 37C for 45 min to allow bleb formation. Blebs were visualized by staining the cells for actin (green) using phalloidin iFluor 488; nuclei were counterstained (red) using TO-PRO3. A representative image field of 20 different image fields is presented. Bar size: 7.5 µm. 
